Stock Report

All about this stock under one free report Last Updated: 27-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Bio-Rad Laboratories Inc. Class A (BIO) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$381.00

up-down-arrow $-6.54 (-1.69%)

As on 25-Sep-2026 16:00EDT

Market cap

info icon

$10,065 Mln

Revenue (TTM)

info icon

$2,589 Mln

P/E Ratio

info icon

45.8

P/B Ratio

info icon

1.4

Div. Yield

info icon

0 %

Edit peer-selector-edit
Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Market cap ($ Mln)
 10,065 24,123 10,486 9,957 9,751
Revenue ($ Mln)
 2,589 17,664 4,140 3,145 3,054
Net Profit ($ Mln)
 222.40 1,114.00 413.58 535.46 375.30
Net Margin (%)
 8.59 6.31 9.99 17.03 12.29
RoE (%)
 3.04 9.93 9.99 11.46 25.55
Price to Earnings
 45.79 18.84 25.99 19.21 26.38
Price-To-Book
 1.43 1.83 2.51 2.12 6.90

Income Statement ($ Mln)

Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Operating Revenue arrow
2,589.30 17,664.00 4,139.53 3,144.90 3,053.50
Cost of Revenue arrow
1,245.50 9,551.00 1,387.59 989.14 883.10
Gross Profit arrow
1,343.60 8,058.00 2,756.90 1,981.10 1,939.90
Operating Expenses arrow
1,108.90 6,392.00 2,200.16 1,504.66 1,654.50
Operating Profit (EBIT) arrow
235.00 1,721.00 551.86 652.69 515.80
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
350.40 1,477.00 568.91 664.95 494.70
Provision for Tax arrow
128.00 364.00 155.33 129.49 119.30
Profit after Tax (Net Income) arrow
222.40 1,114.00 413.58 535.46 375.30
Minority Interest arrow
0.00 -2.00 0.00 0.00 0.00
Consolidated Profit arrow
378.10 579.00 0.00 0.00 0.00

Liabilities ($ Mln)

Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Shareholder's Funds arrow
7,173.90 11,447.00 4,232.45 4,768.60 1,422.20
Minority Interest arrow
0.00 -2.00 0.00 0.00 0.00
Non-Current Liabilities arrow
2,116.80 7,802.00 276.53 240.31 998.70
Current Liabilities arrow
961.30 7,423.00 1,908.60 479.35 744.20
Total Liabilities arrow
10,576.50 26,944.00 6,233.69 5,302.76 3,190.40

Assets ($ Mln)

Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Non-Current Assets arrow
7,231.50 17,371.00 3,754.53 3,272.75 1,316.00
Current Assets arrow
3,020.50 9,330.00 2,663.05 2,215.51 1,849.10
Total Assets arrow
10,576.50 26,944.00 6,233.69 5,302.76 3,190.40
Total Debt* arrow
1,203.70 7,465.00 120.84 111.19 948.40
Net Current Assets arrow
2,059.20 1,907.00 754.45 1,736.17 1,104.90

Cashflow ($ Mln)

Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Cash From Operating Activities arrow
532.20 1,162.00 593.22 753.45 569.30
Cash Flow from Investing Activities arrow
-189.70 -737.00 -112.45 -355.01 -222.70
Cash from Financing Activities arrow
-283.20 107.00 -464.58 -679.16 -595.30
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
ROCE (%) arrow
8.98 4.64 10.09 11.44 9.50
ROE (%) arrow
3.04 9.93 9.99 11.46 25.55
ROA (%) arrow
2.02 3.29 5.00 9.43 8.97
EBIT Margin (%) arrow
-5.99 10.30 15.19 15.11 13.73
Net Margin (%) arrow
8.59 6.31 9.99 17.03 12.29
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Revenue Growth (%) arrow
1.37 -1.08 4.41 19.74 29.41
EBIT Growth (%) arrow
-131.06 59.79 -3.03 36.96 30.76
Net Profit Growth (%) arrow
-30.32 587.65 -5.49 50.14 58.96
EPS Growth (%) arrow
-29.66 579.15 -2.80 50.51 66.81
Book Value Growth (%) arrow
2.19 8.94 9.63 9.65 -1.05

Valuation Ratios

 Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Price / Earnings arrow
10.77 29.23 27.31 22.27 81.29
Price / Book Value arrow
1.10 2.39 2.77 2.62 13.26
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
6.54 11.92 13.35 15.81 38.36
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Debt to Equity arrow
0.11 0.55 0.00 0.00 0.65
Short term debt to equity ratio arrow
0.06 0.10 0.01 0.00 0.01
Current Ratio arrow
3.14 1.26 1.40 4.62 2.48
Quick Ratio arrow
2.33 0.82 1.28 2.93 1.83
Interest Coverage arrow
8.18 5.06 364.75 97.52 8.80

Operating Efficiency Ratios

 Bio-Rad Laboratories Inc. Class A (BIO) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Globus Medical (GMED) Insulet (PODD)
Debtors to sales (%) arrow
17.06 20.36 27.74 23.51 19.28
Asset Turnover arrow
0.24 0.52 0.50 0.55 0.73
Receivable days arrow
65.39 73.75 99.00 82.15 59.51
Inventory Days arrow
221.09 113.36 68.68 270.47 209.92
Payable days arrow
37.02 70.18 32.89 33.17 22.54
Cash Conversion Cycle arrow
249.46 116.92 134.79 319.45 246.89
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...